Correlation Between Calliditas Therapeutics and Enveric Biosciences

Can any of the company-specific risk be diversified away by investing in both Calliditas Therapeutics and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Calliditas Therapeutics and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Calliditas Therapeutics and Enveric Biosciences, you can compare the effects of market volatilities on Calliditas Therapeutics and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Calliditas Therapeutics with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Calliditas Therapeutics and Enveric Biosciences.

Diversification Opportunities for Calliditas Therapeutics and Enveric Biosciences

0.0

Correlation Coefficient

Calliditas Therapeutics  Enveric Biosciences

Pay attention - limited upside

The 3 months correlation between Calliditas and Enveric is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Calliditas Therapeutics and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Calliditas Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Calliditas Therapeutics are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Calliditas Therapeutics i.e., Calliditas Therapeutics and Enveric Biosciences go up and down completely randomly.

Pair Corralation between Calliditas Therapeutics and Enveric Biosciences

If you would invest (100.00) in Enveric Biosciences on February 5, 2024 and sell it today you would earn a total of  100.00  from holding Enveric Biosciences or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Calliditas Therapeutics  vs.  Enveric Biosciences

Calliditas Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Calliditas Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Calliditas Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Enveric Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Enveric Biosciences is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Calliditas Therapeutics and Enveric Biosciences

The main advantage of trading using opposite Calliditas Therapeutics and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Calliditas Therapeutics position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.

The idea behind Calliditas Therapeutics and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.